This is a clinical trial for an intranasal live vaccine to protect against RSV. Vaccine is for children 6-22 months of age and in generally good health. Subjects will receive 2 vaccines 56 days apart. This is a blinded study & placebo controlled. Guardians must be willing keep a diary log of progress and symptoms for the duration of the study.

Study participants may be compensated for time and travel, and receive all study visits and vaccines at no cost. Please contact us for more information about the study, compensation, and to see if your child can qualify. We also reward any referrals of your friends and family who may also be interested in participating in this study.

Contact us with the form below to see if you qualify.

Call or Text! (208) 502-3039

By inputting your information into the form, you consent to receive communication from Leavitt Clinical Research. Msg & data rates may apply. Msg frequency varies. Your information will only be used for communication related to your involvement with Leavitt Clinical Research. Unsubscribe at any time by replying STOP.